ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,473.23
0.77%
Dow Jones
38,778.10
0.49%
US Dollar vs MXN
18.5434
0.04%
Brent Oil
83.625
-0.33%
Bitcoin
65,390.59
-1.65%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Blueprint Medicines Corporation (BPMC)

  7. Blueprint Medicines Corporation (BPMC) Noticias

BPMC Blueprint Medicines Corporation

103.87
-1.68 (-1.59%)
17 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Blueprint Medicines Corporation BPMC NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-1.68 -1.59% 103.87 15:30:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
105.04 102.87 107.60 103.87 105.55
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
14/6/202416:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202416:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202416:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202416:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202416:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202415:00EDGAR2Form 8-K - Current report
07/6/202415:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202415:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202416:11EDGAR2Form 144 - Report of proposed sale of securities
05/6/202415:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202415:40EDGAR2Form 144 - Report of proposed sale of securities
04/6/202415:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202415:28EDGAR2Form 144 - Report of proposed sale of securities
31/5/202415:38EDGAR2Form 144 - Report of proposed sale of securities
30/5/202417:01PRNUSBlueprint Medicines Announces Data Presentations at EAACI..
24/5/202407:00EDGAR2Form 8-K - Current report
23/5/202416:05PRNUSBlueprint Medicines to Present the First Promising and Most..
17/5/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/5/202416:07EDGAR2Form 144 - Report of proposed sale of securities
15/5/202416:05EDGAR2Form 144 - Report of proposed sale of securities
10/5/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/5/202416:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/5/202416:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/5/202415:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
02/5/202406:00PRNUSBlueprint Medicines Reports Strong First Quarter 2024..
18/4/202407:00PRNUSBlueprint Medicines to Report First Quarter 2024 Financial..
11/4/202407:00PRNUSBlueprint Medicines to Host Webcast and Conference Call..
04/4/202415:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
11/3/202417:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202417:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202417:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202417:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202417:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202417:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202417:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202417:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202417:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202415:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202415:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202415:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202415:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202415:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202415:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202415:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
06/3/202409:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202417:19EDGAR2Form 144 - Report of proposed sale of securities
01/3/202414:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NASDAQ
BPMC
Blueprint Medicines
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados